Lesions with Indication for EUS-FNA
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1, Age >20 2, Patients with high risk for thromboembolic event 1)within 2 months after coronary artery stent placement 2)within 12 months after coronary artery drug eluting stent placement 3)within 2 months after cerebral vascular surgery 4)cerebral infarction with stenosis in main artery more than 50% 5)Past history of cerebral infarction and transient ischemic attack 6)ASO with pain during rest 7)past history of cardiogenic cerebral infarction 8)atrial fibrilation with valvular disease 9)atrial fibrilation in patients with high risk for cerebral infarction 10)patients with mechanical heart mitral valve replacement 11)past history of cerebral infarction with mechanical heart valve replacement 12)antiphospholipid syndrome 13)deep venous thrombosis and pulmonary thromboembooism 3, written informed consent was obtained
Exclusion criteria
Exclusion criteria: 1, PS 4 2, ASA >3 3, Pregnancy 4, contraindication for endoscopy 5, Platelate count < 50000/m3 6, PT-INR >2.0 7, EUS-FNA for cystic lesion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A rate of bleeding complication | — |
Countries
Japan
Contacts
Hokkaido University Hospital IRB